β-blockers and Neovascular Age-related Macular Degeneration

Ophthalmology. 2017 Mar;124(3):409-411. doi: 10.1016/j.ophtha.2016.10.023. Epub 2016 Nov 30.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Aged, 80 and over
  • Choroidal Neovascularization / epidemiology*
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Incidence
  • Macular Degeneration / epidemiology*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Adrenergic beta-Antagonists